333 related articles for article (PubMed ID: 38623843)
41. GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics.
Tang T; Gong T; Jiang W; Zhou R
Trends Pharmacol Sci; 2018 Sep; 39(9):798-811. PubMed ID: 30054020
[TBL] [Abstract][Full Text] [Related]
42. [Role of inflammasome NLRP3 in the pathophysiology of viral infections: A focus on SARS-CoV-2 infection].
Chemarin M; Dufies O; Mazet A; Mellan E; Coudereau R; Py BF; Boyer L; Venet F
Med Sci (Paris); 2022; 38(6-7):545-552. PubMed ID: 35766852
[TBL] [Abstract][Full Text] [Related]
43. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.
Xu Q; Zhao B; Ye Y; Li Y; Zhang Y; Xiong X; Gu L
J Neuroinflammation; 2021 May; 18(1):123. PubMed ID: 34059091
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Arch Pharm Res; 2021 Jan; 44(1):16-35. PubMed ID: 33534121
[TBL] [Abstract][Full Text] [Related]
45. NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages.
Moon JS; Nakahira K; Chung KP; DeNicola GM; Koo MJ; Pabón MA; Rooney KT; Yoon JH; Ryter SW; Stout-Delgado H; Choi AM
Nat Med; 2016 Sep; 22(9):1002-12. PubMed ID: 27455510
[TBL] [Abstract][Full Text] [Related]
46. NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma.
McKee CM; Coll RC
J Leukoc Biol; 2020 Sep; 108(3):937-952. PubMed ID: 32745339
[TBL] [Abstract][Full Text] [Related]
47. Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules.
Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Front Immunol; 2020; 11():618231. PubMed ID: 33603747
[TBL] [Abstract][Full Text] [Related]
48. Role and mechanism of the nod-like receptor family pyrin domain-containing 3 inflammasome in oral disease.
Lv K; Wang G; Shen C; Zhang X; Yao H
Arch Oral Biol; 2019 Jan; 97():1-11. PubMed ID: 30315987
[TBL] [Abstract][Full Text] [Related]
49. Protective effect of ginsenoside Rh2 against Toxoplasma gondii infection-induced neuronal injury through binding TgCDPK1 and NLRP3 to inhibit microglial NLRP3 inflammasome signaling pathway.
Jin GN; Lu JM; Lan HW; Lu YN; Shen XY; Xu X; Piao LX
Int Immunopharmacol; 2022 Nov; 112():109176. PubMed ID: 36067653
[TBL] [Abstract][Full Text] [Related]
50. The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging.
Meyers AK; Zhu X
Cells; 2020 Jul; 9(8):. PubMed ID: 32751530
[TBL] [Abstract][Full Text] [Related]
51. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury.
Huang H; Chen HW; Evankovich J; Yan W; Rosborough BR; Nace GW; Ding Q; Loughran P; Beer-Stolz D; Billiar TR; Esmon CT; Tsung A
J Immunol; 2013 Sep; 191(5):2665-79. PubMed ID: 23904166
[TBL] [Abstract][Full Text] [Related]
52. Mechanism and Regulation of NLRP3 Inflammasome Activation.
He Y; Hara H; Núñez G
Trends Biochem Sci; 2016 Dec; 41(12):1012-1021. PubMed ID: 27669650
[TBL] [Abstract][Full Text] [Related]
53. The Human-Specific STING Agonist G10 Activates Type I Interferon and the NLRP3 Inflammasome in Porcine Cells.
Ming SL; Zeng L; Guo YK; Zhang S; Li GL; Ma YX; Zhai YY; Chang WR; Yang L; Wang J; Yang GY; Chu BB
Front Immunol; 2020; 11():575818. PubMed ID: 33072119
[TBL] [Abstract][Full Text] [Related]
54. Apoptosis-associated speck-like protein containing a caspase recruitment domain inflammasomes mediate IL-1β response and host resistance to Trypanosoma cruzi infection.
Silva GK; Costa RS; Silveira TN; Caetano BC; Horta CV; Gutierrez FR; Guedes PM; Andrade WA; De Niz M; Gazzinelli RT; Zamboni DS; Silva JS
J Immunol; 2013 Sep; 191(6):3373-83. PubMed ID: 23966627
[TBL] [Abstract][Full Text] [Related]
55. Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection.
de Sá KSG; Amaral LA; Rodrigues TS; Ishimoto AY; de Andrade WAC; de Almeida L; Freitas-Castro F; Batah SS; Oliveira SC; Pastorello MT; Fabro AT; Zamboni DS
Nat Commun; 2023 Feb; 14(1):1049. PubMed ID: 36828815
[TBL] [Abstract][Full Text] [Related]
56. Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders.
Wani K; AlHarthi H; Alghamdi A; Sabico S; Al-Daghri NM
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33435142
[TBL] [Abstract][Full Text] [Related]
57. Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages.
Son S; Hwang I; Han SH; Shin JS; Shin OS; Yu JW
J Biol Chem; 2017 Dec; 292(50):20437-20448. PubMed ID: 29051224
[TBL] [Abstract][Full Text] [Related]
58. The role of mitochondria in NLRP3 inflammasome activation.
Liu Q; Zhang D; Hu D; Zhou X; Zhou Y
Mol Immunol; 2018 Nov; 103():115-124. PubMed ID: 30248487
[TBL] [Abstract][Full Text] [Related]
59. The RNA- and TRIM25-Binding Domains of Influenza Virus NS1 Protein Are Essential for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1β Secretion.
Moriyama M; Chen IY; Kawaguchi A; Koshiba T; Nagata K; Takeyama H; Hasegawa H; Ichinohe T
J Virol; 2016 Apr; 90(8):4105-4114. PubMed ID: 26865721
[TBL] [Abstract][Full Text] [Related]
60. Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control.
Próchnicki T; Latz E
Cell Metab; 2017 Jul; 26(1):71-93. PubMed ID: 28683296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
